Track the 兰卫医学 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 兰卫医学 has logged 3 insider filings. Market capitalisation: €3.7bn. The latest transaction was reported on 26 March 2024 (Sale). Among the most active insiders: 孙林洁. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.